Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

Background: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by progressive loss of spinal and cortical motor neurons, leading to muscular atrophy, respiratory failure, and ultimately death. There is no known cure, and the clinical benefit of the two drug...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	JosÉ E. De La Rubia, Eraci Drehmer, JosÉ L. Platero, MarÍa Benlloch, Caplliure-Llopis, Jordi, Villaron-Casales, Carlos, Bernardo, Nieves De, AlarcÓn, Jorge, Fuente, Cristian, Carrera, Sandra, Sancho, David, GarcÍa-Pardo, Pilar, Pascual, Raquel, JuÁrez, Marta, Cuerda-Ballester, María, Forner, Alfonso, Sancho-Castillo, Sandra, Barrios, Carlos, Obrador, Elena, Marchio, Patricia, Salvador, Rosario, Holmes, Holly E., Dellinger, Ryan W., Guarente, Leonard, Estrela, José M.
Format:	Dataset
Sprache:	eng
Schlagworte:	Cancer Cell Biology FOS: Clinical medicine FOS: Health sciences Immunology Infectious Diseases Medicine Neuroscience Pharmacology Science Policy
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!